# TransPERineal Fusion Biopsy Versus transrECTal

> **NCT05069584** · NA · COMPLETED · sponsor: **GCS Ramsay Santé pour l'Enseignement et la Recherche** · enrollment: 270 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **PROCEDURE:** Biopsy

## Key facts

- **NCT ID:** NCT05069584
- **Lead sponsor:** GCS Ramsay Santé pour l'Enseignement et la Recherche
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-17
- **Primary completion:** 2023-05-12
- **Final completion:** 2023-05-12
- **Target enrollment:** 270 (ACTUAL)
- **Last updated:** 2023-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05069584

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05069584, "TransPERineal Fusion Biopsy Versus transrECTal". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05069584. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*